strategi remain intact posit
view believ continu success execut
differenti strategi drive attract growth organ
extern manag also aggress past sever
year improv financi posit dilut growth
better posit compani fund develop activ
rate price target unchang
macro trend still support solid demand growth space
compani tenant base continu benefit broadli strong capit
rais environ accord pwc/cb insight moneytre
report ventur capit firm rais billion ytd yoy
earmark biotechnolog life scienc relat ventur
compani whole also success bring new product
market fda alreadi approv nme ytd eclips
trail three-year averag addit nasdaq
biotech index volatil tenant demand wane total
portfolio occup rate continu grind higher increas bp
yoy manag estim top-tier life scienc
cluster market averag avail rate cambridg
seattl see rate low respect
develop platform remain well posit drive solid growth
in-process pipelin substanti consist project
total estim budget billion believ deal alon
drive ffo fulli stabil next year
creat valu addit compani stay activ
sourc new deal fuel on-going develop activ includ
site boston nyc seattl manag also note recent
began due dilig develop north tower nyc aggreg
sf overal compani potenti develop project
compris million sf could break ground intermedi term
anoth million sf could break ground long-term
financi posit solid still plan gradual push leverag lower
manag remain activ rais capit order fund
invest activ estim like rais billion
equiti believ activ push leverag
current go forward manag
highlight would prefer reduc leverag closer
end therefor compani expect rais least million
sell jv stake stabil cambridg asset expect
compani rais anoth million equiti
debt cap
valu usd unless otherwis note
price prior trade day market close estimate unless otherwis note
bloomberg capit market estim upside/downside/target
price target share
larg reflect estim
share expect continu see posit
leas trend in-servic portfolio cash
leas spread modestli increas occup rate
addit expect compani success stabil
develop pipelin properti alreadi
leas aggreg assum cash cap
rate noi
estim compani stock price could reach
high next month upsid scenario
assum compani continu see acceler leas
activ domest intern firm drive
occup bp higher leas spread higher well
solid activ lead increas develop
opportun compani assumpt
would expect cap rate fall bp compani
continu trade premium
estim compani stock price could declin
low next month downsid scenario
assum leas trend weaken in-servic
develop portfolio along correspond increas
interest rate believ trend
minim impact in-servic portfolio could
larger impact develop pipelin
underli valuat stock assumpt
estim underli cash cap rate would increas
inc largest public
life scienc reit one larger public reit
industri believ compani abl drive healthi
organ extern growth posit leas trend
in-servic develop portfolio
macro trend appear healthi tenant base iqvia
formerli im project global pharmaceut sale
increas compound-annual-growth-rate
fda drug approv hit lull agenc approv
new molecular entiti nme approv
nme thu far note tenant will
make long-term real estat decis know
approv drug
leas trend translat stronger growth
compani solid leas activ past sever
quarter million sf leas ytd total
portfolio note mani leas like relat
earli renew leas within develop
developments/redevelop drive
growth estim compani
develop redevelop pipelin add
million addit noi end
furthermor compani activ work advanc
develop pipelin identifi million sf
futur develop million sf intermediate-term
develop project million sf million
sf deliveri respect
risk thesi
biotechnolog sector could binari compani
tenant base oper sector could binari event
exampl septemb aria exercis option
expand space binney street howev octob
compani announc safeti concern around
blockbust drug send share much
howev given qualiti asset tenant still
leas one build abl sub-leas
properti watson
invest book develop reflect
estim compani in-plac
share note develop pipelin
land bank compris invest book
account note valu
estim may volatil time
adjust estim reflect compani lower leverag target
maintain report company-defin ffo estim lower
estim
share respect reduc earn outlook larg driven expect
compani remain aggress rais capit improv financi posit
manag previous highlight target reduc net debt ebitda ratio
also plan reduc leverag closer estim still
impli healthi near-term earn run-rat acceler compani achiev
leverag goal addit estim in-plac given solid
organ extern growth trend estim increas
price target share larg reflect
estim expect continu see posit leas
trend in-servic portfolio modestli increas occup rate addit
expect compani success stabil develop pipelin valuat support
outperform rate
net asset valu in-plac estim assum cap rate
addit expect compani creat solid valu next year therefor
estim increas look estim
share look estim
risk rate price target
greatest risk estim recommend price target relat gener
econom trend includ limit job growth health-car expenditur new
biotechnolog offic suppli access capit addit tenant base requir
signific outlay fund research develop clinic test
product technolog product also subject feder state foreign
regulatori approv higher raw materi labor cost relat develop
threat terror weather key personnel chang outlin compani
file secur exchang commiss
alexandria estat equiti inc largest public life scienc real estat
invest trust reit one larger public reit equiti market capit
approxim billion fulli integr self-administ self-manag
reit focus own oper develop high qualiti cluster lab space major
life scienc market june asset base includ million sf oper
properti includ million sf develop redevelop properti
project deliveri
adjust fund oper affo fad
adjust fund oper affo fad
adjust ffo affo fad share-unit
compani report capit market estim
invest public/priv compani mark mark percentag
net oper incom noi -- consolid unconsolid jv adjust
equival
invest public/priv compani
fmv construction-in-process pipelin basi
held develop estim market valu
leverag -- consolid unconsolid jv adjust
dilut shares-unit equival
compani report capit market estim
